SCHEMBL9259722

SCHEMBL9259722

CC[CH]C([CH]CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532483 0.83
SCHEMBL8835280 0.81
SCHEMBL8002627 0.74
SCHEMBL498637 0.69
SCHEMBL56822 0.67
SCHEMBL9021833 0.65
SCHEMBL1929747 0.65
SCHEMBL9021371 0.65
SCHEMBL142252 0.65
SCHEMBL8002254 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311313-B1 Heterocyclic spiro compounds and their preparation YAMANOUCHI PHARMA CO LTD (JP) 1995-05-10 EP disclosed
US-5412096-A Treatment of senile dementia, Alzheimer*s disease, cholinergic activators YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
US-RE34653-E 1-oxa-8-azaspiro/4,5/decane compounds YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-07-05 US disclosed
US-5041549-A Cholinergin agents YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-08-20 US disclosed
US-4996210-A Cognition activators, nervous system disorders; muscarinic acetylcholine receptor agonists; 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane for example YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-02-26 US disclosed
US-4940795-A Heterocyclic spiro compounds and methods for preparing the same YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1990-07-10 US disclosed
EP-0311313-A2 Heterocyclic spiro compounds and their preparation YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1989-04-12 EP disclosed